Fresenius SE | Cash Flow

Fiscal year is January-December. All values EUR Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,698
1,812
2,344
2,676
3,033
3,714
Depreciation, Depletion & Amortization
902
955
1,124
1,215
1,437
1,495
Other Funds
144
362
661
321
424
876
Funds from Operations
2,528
2,771
3,374
3,896
4,118
4,433
Changes in Working Capital
191
211
25
311
181
691
Net Operating Cash Flow
2,337
2,560
3,349
3,585
3,937
3,742
Capital Expenditures
1,088
1,366
1,511
1,641
1,823
Sale of Fixed Assets & Businesses
24
22
27
25
118
Purchase/Sale of Investments
147
186
364
190
424
Net Investing Cash Flow
3,621
3,326
1,519
2,102
7,570
Cash Dividends Paid - Total
491
225
238
300
343
Issuance/Reduction of Debt, Net
1,886
1,505
1,253
430
4,616
Net Financing Cash Flow
1,306
1,043
1,979
973
3,872
Net Change in Cash
21
311
131
535
57
Free Cash Flow
1,249
1,194
1,838
1,944
2,114
Deferred Taxes & Investment Tax Credit
3
63
61
3
230
100
Net Assets from Acquisitions
2,704
2,168
399
676
6,289
Change in Capital Stock
233
125
173
78
23
Exchange Rate Effect
43
34
18
25
182

About Fresenius SE

View Profile
Address
Else-Kröner-Strasse 1
Bad Homburg Hessen 61352
Germany
Employees -
Website http://www.fresenius.de
Updated 07/08/2019
Fresenius SE & Co. KGaA is a global healthcare group, which engages in the provision of products, and services for dialysis, hospitals, and outpatient medical care. It operates through the following business segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed, and Corporate & Other. The Fresenius Medical Care segment is comprised of dialysis products, and healthcare services.